BioCorRx Inc. Business Combination, Acquisition Related Costs
BioCorRx Inc. (BICX) reported Business Combination, Acquisition Related Costs of $528.62 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-03-31
- BioCorRx Inc. business combination, acquisition related costs for the quarter ending 2025-12-31 was $309.26K.
- BioCorRx Inc. business combination, acquisition related costs for the quarter ending 2025-09-30 was $0.00.
- BioCorRx Inc. business combination, acquisition related costs for the quarter ending 2025-06-30 was $196.46K.
- BioCorRx Inc. business combination, acquisition related costs for the quarter ending 2025-03-31 was $22.90K.
- BioCorRx Inc. business combination, acquisition related costs for fiscal 2025 was $528.62K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $309.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $309.26K derived: sum of 2 quarters · filed 2026-03-31 | $505.72K derived: sum of 3 quarters · filed 2026-03-31 | $528.62K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $196.46K derived: sum of 2 quarters · filed 2025-11-14 | $219.36K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $196.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $219.36K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $22.90K 10-Q · filed 2025-05-15 |